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Abstract
Background: To identify preoperative, perioperative and postoperative risk factors that influence the success of
pterygium surgery.
Methods: This is a prospective study of thirty-six patients with primary or recurrent pterygia. A detailed anamnesis
and an ophthalmological examination were performed looking for the following factors: age, race, latitude and
altitude of the main place of residence, hours of exposure to the sun, use of protective measures against UV-radiation,
classification of pterygium, width of the pterygium at limbus, surgical technique (conjunctival autograft plus suturing
versus tissue glue), graft alterations (misapposition, granuloma, haemorrhage, oedema, retraction or necrosis),
and postoperative symptoms (foreign-body sensation, pain). The examinations were performed 2 and 7 days and 2,
6 and 12 months after surgery. In addition, recurrence was defined as any growth of conjunctiva into the cornea.
Results: A logistic regression and a survival analysis have been used to perform data analysis. A total number of 36
patients completed a one year follow-up. A total of 13 patients were born and lived in Spain, and 26 came from other
countries, mostly Latin America. A total number of 8 males (no women) presented a recurrence, mainly between 2
and 6 months. The hours of sun exposure through their life was independently related to surgical success. Pterygia of
less than 5 mm of base width showed a weak positive correlation with recurrence. None of the other factors
considered were significantly related to recurrence.
Conclusions: Male gender and high sun exposure are strongly and independently related to surgical success after
the removal of pterygia.
Keywords: Risk factors, Sunlight exposure, Pterygium surgery, Conjunctival autograft
Background
Pterygium is a wing-shaped, ﬁbrovascular tissue crossing
the limbus into the cornea. It is a common ocular surface
disease, but also potentially blinding, so diﬀerent surgical
procedures have been used to prevent it. Recurrence
after excision remains a great challenge. Nowadays, it is
accepted that conjunctival autograft surgery is the pro-
cedure of choice for the treatment of both primary and
recurrent pterygium [1,2].
The pathogenesis of pterygia is still not completely
understood. An overall view of the growth process reveals
amultiplicity of factors that are correlated and interrelated
[3]. Recent evidence implicates anti-apoptotic mecha-
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nisms, immunological mechanisms, cytokines, growth
factors, extracellular matrix modulators, genetic factors
and viral infections, among other possible causative
factors [4,5].
The prevalence rates vary widely (from 2% to 29%)
[1], but generally they are higher in the tropics than at
temperate latitudes [6,7]. It is accepted that pterygium
occurs in an equatorial belt delimited by Latitude 40N
and S, associating it with ultra-violet light [7-9]. Preva-
lence increases geographically towards the equator and
is greater in people exposed to outdoor environments
[10]. In addition, there are associations with rural regions,
increasing age and male gender, which correlate with out-
door work [11]. Although a lot has been written about
the risk factors for developing a pterygium, the relation-
ship between them and the outcome of the surgery is still
unclear.
© 2012 Torres-Gimeno et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the
Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use,
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The purpose of our study is to identify preoperative,
perioperative and postoperative risk factors that inﬂuence
the success of pterygium surgery.
Methods
This is a prospective study, involving thirty-six patients
with primary or recurrent pterygia, treated at the
Dr. Peset Hospital (Valencia, Spain) from September
2007 to July 2008. The ethics committee of the Dr. Peset
Hospital CEIC (Comite´ E´tico de Investigacio´n Cl´ınica)
has given its approval to the study in compliance with the
Helsinki Declaration. The reference number is 8/2005.
A total of 13 patients were born and had always lived
in Spain. A total of 26 came from other countries,
mostly Latin America. A comprehensive medical and
ocular history was obtained by a single ophthalmologist
(the coauthor AT). The patient´s age, gender and race
(Caucasian or Hispanic) were recorded. Then a detailed
questionnaire was undertaken in order to evaluate: prin-
cipal place of residence (the name of the place where
he/she lived most of his/her life), exposure to sun over
lifetime (hours per day, during workdays and rest days),
use of sun protection (none, hat, sunglasses, both of
them) and the use of prescription glasses. We looked
for the latitude and altitude of the patient´s principal
place of residence. Furthermore, Snellen visual acuity
measurement, applanation tonometry, slit-lamp examina-
tion, funduscopy and anterior segment photography were
performed pre-operatively. A pterygium was deﬁned as
a radially oriented ﬁbrovascular lesion crossing the nasal
or temporal limbus. Moreover, the pterygia were graded
according to the system used by [12]: grade 1 (atrophic:
episcleral vessels under the body of the pterygium are not
obscured and clearly distinguished), grade 3 (ﬂeshy: epis-
cleral vessels totally obscured) and grade 2 (intermediate:
all other pterygia not falling into these 2 grades). We also
estimated the width of the pterygia at limbus, dividing
them into two groups: wide base (≥ 5mm) and narrow
base (<5 mm). The pterygia sizes were measured with a
slit lamp by using a slit beam of light. Tear break-up time
measurement, evaluation of ocular motility, presence of
symblepharon and previous surgery were also indicated.
Inclusion criteria: Patients were included if they pre-
sented a primary or recurrent pterygia, for which surgery
was recommended considering the following critreria.
(i) A visual disturbance either through pupillary aperture
invasion or by signiﬁcantly inducing corneal astigmatism
(more than 2 diopters measured by corneal topography
and not attributable to other causes). (ii) Documented
enlargement over time in the direction of the centre of the
cornea. (iii) Chronic symptomatic inﬂammation (signif-
icant foreign-body sensation or pain, hyperemia, dellen,
corneal epithelial defect). Exclusion criteria: Subjects with
other pathology features or infection of the ocular surface
that might alter wound healing, mainly connective tissue
disease and diabetes were excluded. All patients gave
written informed consent to participating in the study,
which was approved by the ethical committee of our hos-
pital. Moreover, the surgical procedures complied with
the tenets of the Declaration of Helsinki.
Surgical technique
The surgical technique used is similar to procedures
described earlier. [2,13] Patients were randomized into
2 subgroups: Tissue glue group (TG) and Mersilk group
(MG). Tissue glue was used to attach the auto graft in
21 patients and 7.0 Mersilk sutures were used in 18
cases.
Tissucol Duo (Baxter AG, Vienna, Austria) is a ﬁbrin
solution that simulates the ﬁnal stage of the coagula-
tion cascade. The kit includes 2 syringes, one contain-
ing a solution comprised of factor XIII, plasminogen,
plasma ﬁbronectin and ﬁbrinogen and a second syringe
that contains a human thrombin solution. All patients
were operated on by the same surgeon (LM). The proce-
dure was carried out under topical and subconjunctival
(lidocaine 2%) anaesthetic. Pterygium dissection from the
head towards the body was made. Then the pterygium
head, along with the underlying tenon tissue, was excised.
Episcleral scarring was removed and minimal cauterisa-
tion was used to control bleeding in the recipient bed.
The area of the conjunctival defect was measured with a
caliper, and a free conjunctival-limbal auto graft measur-
ing the same size as the conjunctival defect was obtained
from the superotemporal quadrant of the bulbar conjunc-
tiva. For the graft dissection, 2% lidocaine was injected
under the conjunctiva in order that only conjunctiva be
obtained. The conjunctiva was dissected from the fornix
to the limbus, and graft dissection was extended by 0.5
mm into the clear cornea to include the limbal element of
the graft. Meticulous dissection was performed in order
to remove the Tenon capsule as much as possible. In the
suture group, the limbal part of the graft was attached to
the adjacent conjunctiva and episclera with 2 interrupted
7-0 Mersilk sutures. In the tissue glue group, one drop of
thrombin solution was applied over the bare sclera in the
recipient bed and one drop of protein concentrate solution
was applied over the stromal side of the graft. The graft
was immediately placed in the correct orientation onto
the bare. Postoperative therapy included Tobramycin-
Dexametasone combination every six hours, Pranoprofen
eyedrops every six hours for four weeks and a Povidone
artiﬁcial tear every six hours for two months. The postop-
erative follow-up was carried out by a single ophthalmol-
ogist (AT). The examinations were performed between 2
and 7 days and between 2, 6 and 12 months after surgery.
The anterior segment and the integrity of the autograft
(granuloma formation, subconjunctival haemorrhage,
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edema, necrosis, retraction and gaping or displacement of
the graft-bed junction) were evaluated by slit lamp biomi-
croscopic examination at each visit. Silk sutures were
removed at the one week visit. Recurrence was deﬁned as
any growth of the conjunctiva into the cornea. All patients
were asked about subjective symptoms and graded into 4
groups: asymptomatic, foreign-body sensation, mild pain
or severe pain (deﬁned by the need for an oral analgesic).
At the 2-month visit, visual acuity was also checked and an
anterior segment photograph was taken at the 12-month
visit. Reoperation was performed with the patient´s con-
sent if recurrent pterygium was observed on any follow-
up examination, which happened in just two cases. The
remaining patients that recurred were free of symptoms
and preferred to wait and see evolution.
Statistical analysis
Statistical analysis has been performed using the sta-
tistical software environment R [14]. Logistic regression
(the function glm included in [15]) and survival analy-
sis has been used. The interval censored data has been
analyzed using [16]. Variable selection has been applied.
The method used consists of the minimization of the AIC
(Akaike information criterium). It has been performed
using the function stepAIC included in the R package
MASS [15]. The interval censored data has been analyzed
using the R package interval [16].
Results
Statistical descriptives of the patient ages by taking into
account the recurrence are shown in Table 1: the min-
imum, ﬁrst quartile (or 25% quantile), sample mean,
median, third quartile (or 75% quantile) and the max-
imum. Those patients that suﬀered recurrence were
slightly fewer than those that did not although this diﬀer-
ence was not statistically signiﬁcant. The p-value in the
last column corresponds to the t-test where the mean ages
for recurrence and no recurrence are compared. Table 2
shows the odds ratio (with the corresponding conﬁdence
interval) between recurrence and the diﬀerent variables
under study (transformed into binary variables). It can be
seen that gender is the most important risk factor for sur-
gical outcome. For the remaining variables the conﬁdence
Table 1 Statistical summaries of age where no-rec means
no recurrence cases and rec corresponds to recurrence
casesmeanwhile the p-value corresponds to the t-test
where themean ages for recurrence and no recurrence are
compared
Age Min. Median Mean 3rd Qu. Max. N p-value
All 24.00 45.00 46.21 58.00 77.00 36
No-Rec 24.00 45.00 47.18 58.00 77.00 28 0.4107
Rec. 31.00 37.50 42.75 49.25 68.00 8
interval contains the value one i.e. we cannot reject that
there is no association between the variable considered
and pterygia recurrence. Let us consider the variable giv-
ing us whether the pterygium has recurred after the one
year follow-up, the one-year recurrence (1 = recurrence
and 0 = non-recurrence). Our major aim will be to study
the inﬂuence of some covariables over the one year recur-
rence. The covariables considered are: age (AGE), gender
(GENDER: 1, male; 0, female), race (R, Caucasians and
Hispanics), latitude (LAT), altitude (ALT), workdays sun
exposure (WDE), non-workdays sun exposure (NWDE),
primary vs recurrent pterygia (PR), pterygium type (PT: 1,
2 and 3 according to Tan classiﬁcation), wide base (WB:
less or greater than 5 mm), surgical technique (ST: ﬁbrin
glue and sutures), miss-apposition (MA: 0, not and 1, yes)
and protective measures (PM: 0, none; 1, hat; 2, sunglass).
A logistic regression has been applied where the
binary response is the one-year recurrence. The covari-
ables remaining in the model after variable selection
are GENDER, WDE, NWDE and WB. Table 3 shows
the parameter estimates and the p-values testing a null
coeﬃcient.
Figure 1 displays the probability of recurrence during
the one year follow-up for diﬀerent values of WDE (from
one to ten hours/day of sun exposure on workdays),
NWDE equal to the mean value observed, and the vari-
ables GENDER and WB. Figure 1 shows four lines that
from top to bottom correspond to male without wide
base, male with wide base, female without wide base and
female with wide base. Note that the main diﬀerences
correspond to gender. The diﬀerences due to WB are
clearly smaller. For each eye our protocol gives us the
time from surgery to recurrence. In fact, we are dealing
with interval censored data because for each patient the
time interval when recurrence appears is known. We
have checked each patient at days two and seven, two
months, six months and one year. This interval cen-
sored data has been used to estimate the survival func-
tion S(t) (for each time t, the fraction of patients with
a time to recurrence greater than t). Figure 2 (left) dis-
plays the survival function estimated. The recurrences
mainly appear between 2 and 6 months after surgery.
The interval censored survival times have been com-
pared (log-rank two sample test) for gender and WB. A
signiﬁcant p-value is observed for gender (p<0.001) and
non signiﬁcant for WB (p=0.64). Figure 2 (right) displays
the estimated survival functions considering the gender.
A total of thirty-six patients completed the 12-month
follow-up period and eight of them (22%) presented
a recurrence within a year post-operatively. The most
important variable inﬂuencing surgical success is gender.
All patients that suﬀered a recurrence were male. The sec-
ond most important variable is the hours that the subject
was exposed to sun radiation, mainly during workdays,
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Table 2 Columns “Non recurrence” and “Recurrence” correspond to the number of cases without and with recurrence
respectively; the column%Recurrence contains the percentage corresponding to recurrence cases; for each variable
(gender, latitude, race, wide base,previous surgery, surgical technique andmisapposition), recurrence odds-ratio and
corresponding conﬁdence interval [CI] are given
Non recurrence Recurrence % Recurrence Odds-Ratio [CI]
Gender
Female 23 0 0 72.64
Male 5 8 62 [ 3.62, 1458.15]
(6 hisp. and 2 cauc.)
Latitude
[ 0, 37] 16 5 23 1.25
[ 0.25, 6.29]
[ 37, 100] 12 3 20
Race
Caucasian 10 2 16 0.6
[ 0.10, 3.55]
Hispanic 18 6 25
Widebase
< 5 mm 15 5 25 1.44
[ 0.29, 7.24]
> 5 mm 13 3 19
Primary/Recurrent pterygia
Primary 23 5 2.25
[ 0.38, 13, 16]
Recurrent 5 3
Technique
Glue 14 5 26 1.66
[ 0.33, 8.35]
Suture 14 3 18
Misapposition
No 8 2 20 0.83
[ 0.14, 5.03]
Yes 20 6 23
but also on non-workdays. Patients that recurred were
younger than those who did not recur (but not statistically
signiﬁcant).
Table 3 Estimates of the coeﬃcients and p-values
observed in the reducedmodel (see text for details):WED
=workdays sun exposure, NWDE = non-workdays sun







No clear relationship has been found between the recur-
rence and protective measures (PM), race (R), altitude
(ALT) and latitude (LAT) of the principal place of resi-
dence, pterygium type (PT), primary-recurrent pterygia
(PR), surgical technique (ST) and miss-apposition (MA).
Only a narrow base (less than 5 mm) pterygia showed a
weak positive trend to recurrence.
Discussion
Pterigia is more common in men than in women
[10,11,17-19]. The female gender has been reported as a
marker for lower occupational or recreational exposure
to sunlight. However, greater exposure to the sun alone
cannot explain the male preponderance to developing
pterigia. It is suggested that other unknown factors
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Figure 1 Probabilities of one year follow-up equal to one for
diﬀerent values of working days sun exposure (WDE). From top
to bottom, we have male with narrow base (dotted line), male with
wide base (dotted dashed line), female with narrow base (solid line)
and female with wide base (dashed line).
probably play a role [18,20]. In a paper comparing the out-
comes of pterygium surgery, males and patients under 40
years of age face a greater risk of recurrence [21]. Our
results indicate that the male gender is also strongly and
independently associated with pterigia recurrence after
surgery. Surprisingly, a younger age does not mean a
greater risk of recurrence in our cases.




































Figure 2 Left: Survival function estimated i.e. the proportion of
non-recurrence cases. Right: Estimated survival functions for male
(dashed line) and female (solid line). The abscissa corresponds to days
after surgery.
Epidemiological factors inﬂuencing pterygium develop-
ment have been suggested (chronic sun exposure, peri-
equatorial place of residence, high altitude or dry weather)
[7,17,18,22,23]. Prevalence increases geographically
towards the equator and sun exposure has been reported
as one of the most important factors inﬂuencing pteri-
gyum development [10,17,24-28]. Therefore, keeping the
eyes out of direct sunlight has been defended as beneﬁ-
cial. Measures such as wearing sunglasses or prescription
glasses, have been described as protective factors against
pterygium development [7,24,26,29].
In a retrospective work, 21 hispanic ethnicity has been
reported as a potentially important risk factor for the
recurrence of primary pterygia treated with conjunctival
auto graft. Other important factors such as hours of sun
exposure were not considered.
In Spain, the immigration rate has increased consider-
ably in the last years, until 2008, so all of our patients
spent most of their lifetime in their respective countries.
This circumstance permits us to compare the success of
pterygium surgery depending on some epidemiological
factors. Clinicians observe that in Spanish people pterygia
often develops after the forth decade of life, mainly in out-
door workers, and have an atrophic appearance. However,
pterygia in immigrants that came mainly from the peri-
equatorial countries of Latin America appear at a younger
age and have a more aggressive aspect. We have not found
a signiﬁcant relationship between ethnicity, latitude and
altitude of the main place of residence and surgical recur-
rence. Protective measures against sun radiation, such as
wearing sunglasses, refractive glasses or a hat do not aﬀect
the recurrence ratio in our sample either. We believe that
this is a factor which is diﬃcult to evaluate over an indi-
vidual´s life. However, sun exposure has been the second
most important factor inﬂuencing recurrence. Strong epi-
demiological evidence links exposure to ultraviolet and
visible light with the development of pterygium. It has
been proposed that the focal limbal irradiation of basal
epithelial cells results in the alteration of these cells and a
breakdown of the limbal barrier [30]. Our results indicate
that focal limbal insuﬃciency due to high sun exposure for
years also determines a higher probability of recurrence
after conjunctival grafting.
In our study, narrow base pterygia (less than 5 mm
at the limbus) showed a weak association with recur-
rence. This factor is not usually considered in pterygia
studies. Larger prospective studies should be under-
taken to conﬁrm this. Conjunctival autografting is often
utilized with low recurrence and good success in both
primary and recurrent pterygia. Some surgeons perform
grafting as their standard procedure for the treatment of
both primary and recurrent pterygium. This is due to a
low recurrence rate, eﬃcient limbal reconstruction and
long-term safety compared with other techniques such
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as mitomycine application and beta radiation [1,2,31].
Some authors use a temporal amniotic membrane patch
covering the excised area with low recurrence ratio
[13]. The auto graft can be ﬁxed with sutures or ﬁbrin
glue. The use of a tissue adhesive simpliﬁes the surgical
technique and minimizes postoperative inﬂammation,
reducing both operating time and postoperative pain [32].
What is more, it provides an excellent hemostasis even
in congested eyes with recurrent pterygium [33]. The
recurrence rates when using this surgical technique, vary
from 2% to 34%, depending on individual technique and
surgical experience [1-12]. In addition, we believe that the
follow-up period must be at least one year after surgery in
order to detect all recurrences. When comparing sutures
to ﬁbrin glue, most of the studies show a low recurrence
rate when the graft is attached with glue ([1,2,34-36]), or
at least similar rates with both procedures. 37-39 Besides,
the glued-graft also reduces surgery time and improves
postoperative patient comfort [1,34-39]. We have not
found any diﬀerence in the recurrence ratio between
both procedures. In addition, depending on postoperative
alterations in the graft (granuloma, edema, haemorrhage,
retraction, misapposition or necrosis), they showed no
relationship with recurrence ratio either.
Conclusion
Epidemiological and clinical aspects inﬂuencing pterygia
development have been extensively studied, but few
works consider those factors related to surgery failure.
Our results indicate that male gender and sun exposure
are strongly and independently related to surgical success
after pterygia removal. We believe that sun exposure over
life and male gender should be considered as additional
risk factors for recurrence after pterygium autograft.
Extremely meticulous surgery and close follow up must
be employed when operating these patients. We are aware
about the small sample sizes. We have a small number
of patients evaluated. Clearly, this is a limitation of our
paper and consequently we have a small statistical power.
Larger studies should be carrier out in order to conﬁrm
our results.
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